Chronic hepatitis C: Treat or wait? Medical decision making in clinical practice

by Niederau, Claus, Hüppe, Dietrich, Zehnter, Elmar, Möller, Bernd, Heyne, Renate, Christensen, Stefan, Pfaff, Rainer, Theilmeier, Arno, Alshuth, Ulrich, Mauss, Stefan
Published 2012

Age-related differences in response to peginterferon alfa-2a/ribavirin in patients with chronic hepatitis C infection

by Roeder, Claudia, Jordan, Sabine, Schulze zur Wiesch, Julian, Pfeiffer-Vornkahl, Heike, Hueppe, Dietrich, Mauss, Stefan, Zehnter, Elmar, Stoll, Sabine, Alshuth, Ulrich, Lohse, Ansgar W, Lueth, Stefan
Published 2014

Benefit of Treatment Individualization in Patients with Chronic Hepatitis C Receiving Peginterferon Alfa-2a and Ribavirin in a Large Noninterventional Cohort Study

by Hofmann, Wolf Peter, Mauss, Stefan, Lutz, Thomas, Schober, Andreas, Böker, Klaus, Moog, Gero, Baumgarten, Axel, Pfeiffer-Vornkahl, Heike, Alshuth, Ulrich, Hüppe, Dietrich, Wedemeyer, Heiner, Manns, Michael P., Schott, Eckart
Published in PLoS One (2015)

Predictive Factors for Sustained Virological Response after Treatment with Pegylated Interferon α-2a and Ribavirin in Patients Infected with HCV Genotypes 2 and 3

by Niederau, Claus, Mauss, Stefan, Schober, Andreas, Stoehr, Albrecht, Zimmermann, Tim, Waizmann, Michael, Moog, Gero, Pape, Stefan, Weber, Bernd, Isernhagen, Konrad, Sandow, Petra, Bokemeyer, Bernd, Alshuth, Ulrich, Steffens, Hermann, Hüppe, Dietrich
Published 2014

Final analysis of the international observational S-Collate study of peginterferon alfa-2a in patients with chronic hepatitis B

by Marcellin, Patrick, Xie, Qing, Woon Paik, Seung, Flisiak, Robert, Piratvisuth, Teerha, Petersen, Jörg, Asselah, Tarik, Cornberg, Markus, Ouzan, Denis, Foster, Graham R., Papatheodoridis, Georgios, Messinger, Diethelm, Regep, Loredana, Bakalos, Georgios, Alshuth, Ulrich, Lampertico, Pietro, Wedemeyer, Heiner
Published in PLoS One (2020)